Eisuke Mekada

Immunology and Microbiology · Life Sciences

54h-index10.4kcitations175works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Toxin Mechanisms and Immunotoxins(45), HER2/EGFR in Cancer Research(36), Monoclonal and Polyclonal Antibodies Research(33), Transgenic Plants and Applications(33), Cell Adhesion Molecules Research(31)

Publications175 total

Supplementary Methods, Figure Legends 1-6 from HB-EGF and PDGF Mediate Reciprocal Interactions of Carcinoma Cells with Cancer-Associated Fibroblasts to Support Progression of Uterine Cervical Cancers
2023Open Access
Supplementary Tables 1-2, Figures 1-6 from HB-EGF and PDGF Mediate Reciprocal Interactions of Carcinoma Cells with Cancer-Associated Fibroblasts to Support Progression of Uterine Cervical Cancers
2023Open Access
Supplementary Figure 2 from Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
2023Open Access
Data from Membrane Type 1-Matrix Metalloproteinase Cleaves Off the NH<sub>2</sub>-Terminal Portion of Heparin-Binding Epidermal Growth Factor and Converts It into a Heparin-Independent Growth Factor
2023Open Access
Supplementary Legends from Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
2023Open Access
Data from HB-EGF and PDGF Mediate Reciprocal Interactions of Carcinoma Cells with Cancer-Associated Fibroblasts to Support Progression of Uterine Cervical Cancers
2023Open Access
Data from Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
2023Open Access
Supplementary Tables 1-2, Figures 1-6 from HB-EGF and PDGF Mediate Reciprocal Interactions of Carcinoma Cells with Cancer-Associated Fibroblasts to Support Progression of Uterine Cervical Cancers
2023Open Access
Supplementary Methods, Table 1, Figures 1-8 from Membrane Type 1-Matrix Metalloproteinase Cleaves Off the NH<sub>2</sub>-Terminal Portion of Heparin-Binding Epidermal Growth Factor and Converts It into a Heparin-Independent Growth Factor
2023Open Access
Supplementary Figure 1 from Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
2023Open Access
Supplementary Figure 2 from Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
2023Open Access
Supplementary Methods, Figure Legends 1-6 from HB-EGF and PDGF Mediate Reciprocal Interactions of Carcinoma Cells with Cancer-Associated Fibroblasts to Support Progression of Uterine Cervical Cancers
2023Open Access
Data from HB-EGF and PDGF Mediate Reciprocal Interactions of Carcinoma Cells with Cancer-Associated Fibroblasts to Support Progression of Uterine Cervical Cancers
2023Open Access
Supplementary Methods, Table 1, Figures 1-8 from Membrane Type 1-Matrix Metalloproteinase Cleaves Off the NH<sub>2</sub>-Terminal Portion of Heparin-Binding Epidermal Growth Factor and Converts It into a Heparin-Independent Growth Factor
2023Open Access
Data from Membrane Type 1-Matrix Metalloproteinase Cleaves Off the NH<sub>2</sub>-Terminal Portion of Heparin-Binding Epidermal Growth Factor and Converts It into a Heparin-Independent Growth Factor
2023Open Access
Supplementary Figure 1 from Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
2023Open Access
Data from Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
2023Open Access
Supplementary Legends from Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
2023Open Access
Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation
Nature Immunology·2022· 81 citedOpen Access
Spread of genetically similar noroviruses in Bangkok, Thailand, through symptomatic and asymptomatic individuals
Heliyon·2021· 4 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Ryo Iwamoto(17), Shigeki Higashiyama(8), Kenji Miyado(6), Michael Klagsbrun(6), Toshiyuki Umata(6), Shingo Miyamoto(6), Hiroshi Yagi(6), Kenzo Sonoda(6), T. Mitamura(5), Naoyuki Taniguchi(4), Ayano Yamazaki(4), Hiroto Mizushima(4), Makoto Tsuneoka(4), Takafumi Uchida(4), Hidetoshi Hasuwa(3), Michinari Hirata(3), Hitoo Nakano(3), Fusanori Yotsumoto(3), Hiroki Moribe(3), Yasunori Okada(3)